Hylek EM - Search Results

1

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.

Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, Held C, Alexander JH, Vinereanu D, Flaker GC, Hylek EM, Lopes RD. Al-Khatib SM, et al. Among authors: hylek em. Circulation. 2022 Sep 20;146(12):958-960. doi: 10.1161/CIRCULATIONAHA.122.059438. Epub 2022 Sep 19. Circulation. 2022. PMID: 36121911 No abstract available.

2

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE. Go AS, et al. Among authors: hylek em. Circulation. 2000 Jul 4;102(1):11-3. doi: 10.1161/01.cir.102.1.11. Circulation. 2000. PMID: 10880408

3

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.

Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM. Garcia D, et al. Among authors: hylek em. Chest. 2005 Jun;127(6):2049-56. doi: 10.1378/chest.127.6.2049. Chest. 2005. PMID: 15947319

4

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Fang MC, et al. Among authors: hylek em. Circulation. 2005 Sep 20;112(12):1687-91. doi: 10.1161/CIRCULATIONAHA.105.553438. Epub 2005 Sep 12. Circulation. 2005. PMID: 16157766 Free PMC article.

5

Antithrombotic therapy in atrial fibrillation.

Garcia DA, Hylek EM. Garcia DA, et al. Among authors: hylek em. Clin Geriatr Med. 2006 Feb;22(1):155-66, x. doi: 10.1016/j.cger.2005.09.011. Clin Geriatr Med. 2006. PMID: 16377472 Review.

6

The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Garcia DA, Regan S, Crowther M, Hylek EM. Garcia DA, et al. Among authors: hylek em. J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. doi: 10.1016/j.jacc.2005.09.058. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487849 Free article.

7

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.

Garcia D, Hylek E. Garcia D, et al. ACP J Club. 2007 Mar-Apr;146(2):52. ACP J Club. 2007. PMID: 17335175 No abstract available.

8

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.

Garcia D, Hylek E. Garcia D, et al. Evid Based Med. 2007 Apr;12(2):57. doi: 10.1136/ebm.12.2.57. Evid Based Med. 2007. PMID: 17400649 No abstract available.

9

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Hylek EM, et al. Circulation. 2007 May 29;115(21):2689-96. doi: 10.1161/CIRCULATIONAHA.106.653048. Epub 2007 May 21. Circulation. 2007. PMID: 17515465

10

Stroke prevention in elderly patients with atrial fibrillation.

Garcia D, Hylek E. Garcia D, et al. Lancet. 2007 Aug 11;370(9586):460-1. doi: 10.1016/S0140-6736(07)61208-2. Lancet. 2007. PMID: 17693158 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page